Skip to main content
. 2021 Jul 18;13(7):1097. doi: 10.3390/pharmaceutics13071097

Figure 2.

Figure 2

Figure 2

(A) Representative PET slices of two mice from the [89Zr]Zr(OH)2(C2O4) control group 24 h post-injection, and (B) of four mice that received the [89Zr]Zr(oxinate)4–liposomes. (C) Time–-activity curves of selected organs (liver, spleen, kidney and bone) generated from the dynamic PET imaging data over 55 min post-injection.